CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $4,240 | +94.2% | 100 | 0.0% | 0.00% | – |
| Q3 2023 | $2,183 | -31.3% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $3,179 | +30.3% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $2,439 | -22.7% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $3,154 | +11.6% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $2,826 | +6.9% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $2,644 | -24.5% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $3,501 | +8.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,242 | +9.9% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $2,950 | +15.1% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,562 | +86.6% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,373 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,912,345 | 41.46% |
| Perceptive Advisors | 6,511,727 | $205,379,869 | 5.77% |
| Finepoint Capital LP | 517,287 | $16,315 | 5.28% |
| Artal Group S.A. | 1,900,000 | $59,926 | 3.34% |
| Affinity Asset Advisors, LLC | 215,000 | $6,781,100 | 2.66% |
| Rock Springs Capital Management LP | 2,506,464 | $79,053,875 | 1.90% |
| Hood River Capital Management LLC | 923,638 | $29,131,543 | 1.06% |
| Logos Global Management LP | 260,000 | $8,200,400 | 0.96% |
| Frazier Life Sciences Management, L.P. | 393,000 | $12,395,220 | 0.77% |
| FEDERATED HERMES, INC. | 2,867,451 | $90,439,405 | 0.25% |